Huntsman Carole 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Huntsman Carole
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-03-03$313.08/sh−71$22,229→ 10,367 total - Sale
Common Stock
2025-03-03$314.74/sh−200$62,948→ 10,167 total - Sale
Common Stock
2025-03-03$320.21/sh−300$96,063→ 9,867 total - Sale
Common Stock
2025-03-03$323.65/sh−200$64,730→ 9,667 total - Sale
Common Stock
2025-03-03$324.59/sh−200$64,918→ 9,467 total - Sale
Common Stock
2025-03-03$326.34/sh−100$32,634→ 9,367 total - Sale
Common Stock
2025-03-03$327.49/sh−100$32,749→ 9,267 total - Sale
Common Stock
2025-03-03$329.64/sh−100$32,964→ 9,167 total - Sale
Common Stock
2025-03-03$335.00/sh−563$188,605→ 8,604 total
Footnotes (5)
- [F1]These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.40 to $315.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.13 to $320.32, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.47 to $323.83, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.48 to $324.70, inclusive.